Neurons treated with thapsigargin had reduced neuronal expression of autophagy-specific markers, beclin-1, ATG3, ATG7, and LC3B, compared to the control ( p 0.001)
Contraindications & Precautions Semaglutide is not appropriate for everyone
Status as of mid-2026: Retatrutide is still investigational
When you stop the medication, your body's natural GLP-1 production doesn't instantly fill that gapappetite hormones rebound, and satiety signals fade
States are taking different approaches to GLP1 coverage for obesity, some require it under Medicaid or state employee plans, while others have cut it due to cost
GLP-1s diabetes benefits include substantial A1C reductions (typically 1-1.5% or more), low hypoglycemia risk due to glucose-dependent mechanism, weight loss rather than weight gain (unlike insulin and many other diabetes medications), cardiovascular protection demonstrated in outcome trials, and potential slowing of disease progression by preserving beta cell function